Dimensional Fund Advisors LP Immuneering Corp Transaction History
Dimensional Fund Advisors LP
- $405 Billion
- Q4 2024
A detailed history of Dimensional Fund Advisors LP transactions in Immuneering Corp stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 13,366 shares of IMRX stock, worth $25,128. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,366
Previous 13,366
-0.0%
Holding current value
$25,128
Previous $33,000
12.12%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IMRX
# of Institutions
45Shares Held
4.87MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.06MShares$1.99 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD810KShares$1.52 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$1 Million0.0% of portfolio
-
Morgan Stanley New York, NY449KShares$844,7040.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny246KShares$462,9870.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $49.6M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...